Quick take: Glove makers skid on Covid-19 vaccine trial positive data


KUALA LUMPUR: News of positive data from the Pfizer-BioNTech Covid-19 vaccine trial sent shares of glove manufacturers plunging in early trade Tuesday.

The sell-off wiped out the considerable gains the shares had over recent gains.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Hartalega , Top Glove , Supermax , Kossan , glove

   

Next In Business News

Wall St set to rise ahead of speeches from Fed officials
Sarawak Cable finds new hope as alternative party is identified
Main Market-bound Feytech IPO public portion oversubscribed
Bursa lifts Awantec's affected issuer status
SC charges Pixelvest and former Infinity Trustee director with unlicensed capital market offences
Ringgit ends firmer against US dollar
InNature buys 'Burger & Lobster' franchise, eyes expansion into F&B Sector
Bank Negara fines Habib with RM96,250 for AMLA non-compliance
Pharmaniaga says 'stands firm' on financial recovery to exit PN17
Kobay gets UMA query from Bursa Malaysia

Others Also Read